Some very good points have been made regarding this PR.1.) On or before the 20th of August we will all
know what the o/s count is based on the number of shares we are each issued of UCAD.
2.) The number of shares of UCAD per one
million shares of CMKX (assuming 400B o/s)
is 18.75.
7.5M/400B = 0.00001875 UCAD shares per CMKX shares
1,000,000 CMKX shares = 18.75 UCAD Shares
18.75 UCAD shares = $63.75 in today's dollars
3.) If the O/S is less than 400B then we
are all in much better shape...
The value per share (assuming 400B o/s)
is $510M/400B = .001275 roughly 3x
where the pps is currently.
(all of this is using worst case senario
numbers.)
4.) As Van pointed out the Book value has
essentially also been established. If 5%
of "all" claims as stated in the PR is being
purchased for $25.5M then the intrinsic value
can be assumed to be $510M.
This is not to say that the company is not
worth more. This is the value based on the
value placed on the claims sold.
Unfortunately we cannot put a P/E of 10 or 20 on the value at this point because we
do not have any earnings. IMHO
5.) As of May 18th 2004 UCAD had 7.7 Million
common shares outstanding. Initially this
might mean something but eventually this
can be diluted with the issuance of more shares...
UCAD has 100M a/s with a reverse 125:1
which occurred at the beginning of the
year...